Encodia

Encodia Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 7

Encodia General Information

Description

Developer of a highly-parallelized protein analysis platform intended to study proteomes easily. The company's platform is user-friendly that analyzes protein samples on an unprecedented scale, enabling researchers to create parallelized approaches to protein analysis.

Contact Information

Website
Formerly Known As
ProCure Life Sciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 11125 Flintkote Avenue
  • Suite B
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Encodia Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Encodia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 20-Jul-2018 $4M 0000 00000 Completed Startup
3. Early Stage VC (Series B) 25-Sep-2017 0000 0000 00000 Completed Startup
2. Grant 01-Jan-2017 $435K $10M Completed Startup
1. Early Stage VC (Series A) $10M $10M 0000 Completed Startup

Encodia Cap Table

To view Encodia‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000

Encodia Executive Team (4)

Name Title Board Seat Contact Info
Mark Chee Ph.D Co-Founder, Board Member & President
Kevin Gunderson Ph.D Co-Founder, Vice President & Chief Technology Officer
Michael Weiner Ph.D Co-Founder & Board Member
Jack Beierle Senior Director, Chemistry & Materials

Encodia Board Members (4)

Name Representing Role Since
David Cruikshank ARCH Venture Partners Board Member 000 0000
Julie Sunderland Biomatics Capital Board Member 000 0000
Mark Chee Ph.D Encodia Co-Founder, Board Member & President 000 0000
Michael Weiner Ph.D Encodia Co-Founder & Board Member 000 0000

Encodia Investors (7)

To view Encodia‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Decheng Capital Venture Capital Minority 000 0000 000000 0
NFLS - Pivotal Venture Capital Minority 000 0000 000000 0
Tao Capital Partners Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Biomatics Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial